Results 111 to 120 of about 1,439 (137)

Current status of COVID-19 treatment: An opinion review. [PDF]

World J Virol, 2020
Di Franco S, Alfieri A, Petrou S, Damiani G, Passavanti MB, Pace MC, Leone S, Fiore M.   +7 more
europepmc   +1 more source

Incidence of Electrolyte Imbalances Following Traumatic Rhabdomyolysis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Safari S, Aghili SH, Shahlaee MA, Jamshidi Kerachi A, Farhang Ranjbar M.   +4 more
europepmc   +1 more source

[Dose adjustment according to renal function in a polymedicated patient included in the medication reconditioning service using medication compliance aids (MCA)]. [PDF]

Farm Comunitarios
Barris Blundell D, Mousavi H.
europepmc   +1 more source

[Does ezetimibe combined with simvastatin increase the risk of renal failure]. [PDF]

Aten Primaria, 2014
Fernández-Liz E, Ortí Segarra C, Garrido Mesas I.   +2 more
europepmc   +1 more source

[Therapeutic drug option for dyslipaemia]. [PDF]

Aten Primaria, 2010
Maiques Galan A, Brotons Cuixart C.
europepmc   +1 more source

[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?] [PDF]

Semergen, 2020
Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL, Gorriz JL.   +4 more
europepmc   +1 more source

Prevalence of systemic complications of COVID-19 in critically ill patients: systematic review with meta-analysis. [PDF]

Rev Lat Am Enfermagem
Sawada NO, Reis TMD, Freitas PS, Moraes CM, Peloso-Carvalho BM, Assunção MRS, Horvath CMSP, Silva RS, Mendes KDS.   +8 more
europepmc   +1 more source

[Rhabdomyolysis induced by cerivastatin]. [PDF]

Aten Primaria, 2001
Hernanz Hernanz P, Rodríguez Hermida B, Sainza Rúa T, Ortega Inclán MN.   +3 more
europepmc   +1 more source